Episode

Advancing Allogeneic Cell Therapy for SCI and Blindness with Lineage's Brian Culley

Podcast: Cell & Gene: The Podcast
Published: Oct 23, 2025
Duration seconds: 1583
Processing state: not_requested
Canonical source: https://www.buzzsprout.com/1810482/episodes/18047894-advancing-allogeneic-cell-therapy-for-sci-and-blindness-with-lineage-s-brian-culley.mp3
Audio: https://www.buzzsprout.com/1810482/episodes/18047894-advancing-allogeneic-cell-therapy-for-sci-and-blindness-with-lineage-s-brian-culley.mp3
JSON: /v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/advancing-allogeneic-cell-therapy-for-sci-and-blindness-with-lineage-s-brian-culley
Markdown: /podcast/cell-gene-the-podcast-4048431/advancing-allogeneic-cell-therapy-for-sci-and-blindness-with-lineage-s-brian-culley.md

Actions

POST https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/advancing-allogeneic-cell-therapy-for-sci-and-blindness-with-lineage-s-brian-culley/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/cell-gene-the-podcast-4048431/advancing-allogeneic-cell-therapy-for-sci-and-blindness-with-lineage-s-brian-culley.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

We love to hear from our listeners. Send us a message. On episode 114 of Cell & Gene: The Podcast, Host Erin Harris talks to Brian Culley, CEO of Lineage Cell Therapeutics, about advancing cell therapy beyond oncology and into transformative treatments for conditions such as spinal cord injury and blindness. Culley shares how Lineage’s allogeneic, off-the-shelf approach, anchored by its OPC1 program, aims to replace lost or damaged cells to restore function, starting with patients who hav...